---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-072343"
form_type: "8-K"
ticker: "ASTH"
cik: "0001083446"
company_name: "Astrana Health, Inc."
filed_at: "2026-06-10T20:15:42+00:00"
generated_at: "2026-06-10T20:24:15.996413+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Astrana Health shareholders approve 1M-share increase to 2024 equity plan, re-elect all nine directors

## Summary
- Shareholders approved an amendment to the 2024 Equity Incentive Plan, increasing shares reserved by 1,000,000 to a total of 5,100,000 shares.
- All nine director nominees were elected, including Kenneth Sim, Thomas Lam, John Chiang, Weili Dai, Linda Dong, J. Lorraine Estradas, Mitchell Kitayama, Matthew Mazdyasni, and David Schmidt.
- Ernst & Young was ratified as independent auditor for FY 2026 with 43.7M votes for, and the say-on-pay proposal passed with 34.1M votes for.
- The share reserve increase extends the plan term to March 24, 2036; the plan originally effective from 2024.

## SEC filing metadata
- accession: 0001104659-26-072343
- form_type: 8-K
- ticker: ASTH
- cik: 0001083446
- company_name: Astrana Health, Inc.
- filed_at: 2026-06-10T20:15:42+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1083446/000110465926072343/0001104659-26-072343-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1083446/000110465926072343/tm2614755d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-072343
- JSON: https://secwatch.observer/filing/0001104659-26-072343.json
- Plain text: https://secwatch.observer/filing/0001104659-26-072343.txt

## Key facts
- Shareholder Votes
  Astrana Health, Inc. shareholders approved Election of nine directors to the Board, each to hold office until the 2027 Annual Meeting of Stockholders. at the 2026-06-10 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-10
  source text: The voting results for each such matter were as follows: Proposal 1. Election of Directors Nominee For Withheld Broker Non-Votes Kenneth Sim, M.D. 33,456,519 1,959,958 8,356,118 Thomas S. Lam, M.D., M.P.H. 33,486,509 1,929,968 8,356,118 John Chiang 34,104,046 1,312,431 8,356,118 Weili Dai 33,926,696 1,489,781 8,356,118 Linda Dong 33,330,641 2,085,836 8,356,118 J. Lorraine Estradas, R.N., B.S.N. M.P.H. 32,171,774 3,244,703 8,356,118 Mitchell W. Kitayama 33,320,506 2,095,971 8,356,118 Matthew Mazdyasni 33,610,789 1,805,688 8,356,118 David G. Schmidt 33,198,453 2,218,024 8,356,118
  evidence_url: https://www.sec.gov/Archives/edgar/data/1083446/000110465926072343/0001104659-26-072343-index.htm
- Shareholder Votes
  Astrana Health, Inc. shareholders approved Approval of the 2024 Plan. at the 2026-06-10 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2026-06-10
  source text: Proposal 4. Approval of the 2024 Plan For Against Abstain Broker Non-Votes 34,679,879 701,303 35,295 8,356,118
  evidence_url: https://www.sec.gov/Archives/edgar/data/1083446/000110465926072343/0001104659-26-072343-index.htm
- Shareholder Votes
  Astrana Health, Inc. shareholders approved Advisory vote on the compensation program for the Company's named executive officers as disclosed in the Proxy Statement. at the 2026-06-10 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-06-10
  source text: 3. The compensation program for the Company’s named executive officers as disclosed in Proxy Statement was approved, on an advisory, non-binding basis.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1083446/000110465926072343/0001104659-26-072343-index.htm
- Shareholder Votes
  Astrana Health, Inc. shareholders approved Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-06-10 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-10
  source text: 2. The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1083446/000110465926072343/0001104659-26-072343-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.